As President of Terminals for Kinder Morgan, Inc., Mr. Schlosser oversees the largest independent network of liquids and bulk terminals in North America. Kinder Morgan's terminals have approximately 88 million barrels of liquids capacity and handle about 100 million tons of bulk materials annually. The liquids terminals store petroleum products and chemicals and the bulk facilities store and handle coal, petroleum coke and other materials. Additionally, the Terminals business owns Jones Act product tankers that are engaged in the marine transportation of crude oil, condensate and refined products in the United States.  Kinder Morgan Terminals generates approximately $20B in annual revenue and $1.2B in annual EBITDA.

Mr. Schlosser holds a Bachelor of Science degree in science from Miami University, Oxford, Ohio. He is a past chairman and member of the Houston Chapter’s American Diabetes Association. He also serves on the board of directors for the Greater Houston Port Bureau and on the board of the Kinder Morgan Foundation. Mr. Schlosser has two children, Elizabeth and Clay.

Tracey D. Brown is Chief Executive Officer of the American Diabetes Association (ADA), the nation’s largest voluntary health organization and a global authority on diabetes.

Tracey joined the ADA in June 2018 after her tenure as senior vice president of operations and chief experience officer at Sam's Club, a division of Walmart, Inc., where she was responsible for creating meaningful member experiences, directing member strategy, marketing and branding, go-to-market execution, data and analytics and membership operations. 

Tracey brings more than 25 years of experience in driving global business growth, leveraging data to connect consumers with brands and creating omni-channel experiences to escalate customer loyalty. Prior to joining Sam’s Club, Tracey was chief executive officer and managing director of RAPP Dallas, a data-driven integrated marketing agency. Before RAPP, she served as chief operating officer for direct marketing agency Direct Impact, where she coordinated strategic, tactical and overall company operations.

Previously, Tracey was director of worldwide consumer marketing for Advanced Micro Devices, where she drove global marketing and demand generation activity around the world, including China, India, Russia, France, Spain, Italy and Japan. Early in her career, she served in leadership positions at American Express, Proctor & Gamble and Exxon Mobil.

Tracey earned a master of business administration degree from Columbia Business School in New York and a bachelor of chemical engineering degree from the University of Delaware. 

Tracey, who lives with type 2 diabetes, recently served as a volunteer and fundraiser for the ADA in her local community. She joined the ADA’s National Board of Directors in January 2018, before transitioning to her new role as CEO. She and her family resides in the Washington, D.C. metropolitan area. 

Ruth S. Weinstock is SUNY Distinguished Service Professor and Division Chief of Endocrinology, Diabetes and Metabolism in the Department of Medicine at SUNY Upstate Medical University, Syracuse NY. She is also the Medical Director of the Clinical Research Unit and Medical Director of the Joslin Diabetes Center at Upstate Medical University. Dr. Weinstock graduated from Smith College summa cum laude with Highest Honors in the Biological Sciences and received her MD and PhD degrees from Columbia University. She received the SUNY Research Foundation Award Honoring Research in Science, Engineering and Medicine, the SUNY Chancellor’s Award for Excellence in Scholarship and Creative Activities, the American Diabetes Association Outstanding Physician-Clinician Award, and the Samuel Elchoid II Memorial Award for Contributions in Diabetes from the American College of Physicians. Her research over the past 30 years has focused on the study of new approaches for the prevention and management of diabetes mellitus and its complications, including studies examining the feasibility, acceptability and effectiveness of telemedicine for different underserved populations with diabetes delivered to a variety of settings. Dr. Weinstock is a member of numerous professional organizations. She has >200 publications and has served on grant review panels for the National Institutes of Health (NIDDK), on the National Board of Directors and numerous committees of the American Diabetes Association over the past >25 years and as Associate Editor of Diabetes Care as well as Section Editor for Endocrinology for the Mayo Clinic Proceedings, on the editorial board of Endocrinology, on national committees for the Department of Veterans Affairs, as well as on other national, regional and local committees and task forces related to diabetes research and improving diabetes care.  

Cynthia E. Muñoz, PhD, MPH, is a bilingual licensed psychologist who holds an appointment as Assistant Professor of Clinical Pediatrics at the University of Southern California Keck School of Medicine. She has a PhD in Clinical Psychology and an MPH in Maternal and Child Health. Currently, she provides clinical care to children and youth with diabetes at the Children’s Hospital Los Angeles. She also conducts research targeting behavioral health issues associated with pediatric insulin-treated diabetes. Dr. Muñoz co-developed a group intervention, TEEN POWER^®, in 2006 for adolescents and youth with insulin-treated diabetes, siblings, and caregivers. With the generous support of the Sugar Ray Leonard Foundation and the Beatson-ABHOW Type 1 Diabetes Fund, this program expanded to include groups for children starting at 6 years of age. In addition to providing clinical care and conducting clinical research, Dr Muñoz is the ADA’s President of Health Care and Education, President of the ADA’s Community Leadership Board in Los Angeles, and a member of the ADA’s national Safe at School Working Group. She is also a member of the ADA Mental Health Diabetes Education Program’s Steering Committee whose collaborative efforts aim to increase the capacity of mental health professionals who treat people with diabetes. 

Christopher K. Ralston, JD, is a partner and practice coordinator in the New Orleans litigation practice at Phelps Dunbar LLP. Mr. Ralston handles a range of commercial litigation and focuses in the areas of antitrust law, business torts, trade secret litigation and contract disputes, tax litigation, securities litigation and arbitration, direct selling and intellectual property litigation. He also serves as a part of the firm’s appellate practice. Mr. Ralston’s work in the legal field has received recognition in numerous forms: in 2009, he received the Louisiana State Bar Association’s Friend of Pro Bono Award; in 2012, he was named to the New Orleans City Business Hall of Fame; and in 2016, he received both the Federal Bar Association’s New Orleans Chapter President’s Award and the Louisiana State Bar Association’s President’s Award. After recognizing the devastating impact of diabetes in New Orleans, Mr. Ralston joined the ADA’s New Orleans Community Leadership Board (CLB) in 2009, and he has served as Chair of the CLB since 2014.

Glen Tullman is Founder and former Executive Chairman of Livongo and is passionately committed to finding a cure for diabetes and other chronic conditions and keeping people healthy until we do. A visionary leader and entrepreneur, he previously ran two public companies that changed the way healthcare is delivered. Tullman is also a co-founder and partner in 7wireVentures, an early-stage investment firm focused on healthcare He is the author of On Our Terms: Empowering the New Health Consumer, which proposes new solutions to address the chronic-condition epidemic facing our country.

Guillermo Umpierrez, MD, CDE, is professor of medicine in the Division of Endocrinology, and Director of the diabetes and endocrinology section at Grady Memorial Hospital, Atlanta, Georgia.  He is the recipient of numerous teaching awards for Best Clinical Teacher and Mentor at Emory University, and national awards from the American College of Physicians, American Association of Clinical Endocrinologists, Endocrine Society and the American Diabetes Association. Dr. Umpierrez is a member of the ADA National Board of Directors and will serve as the ADA President-Elect in 2021. 

His research interests include mechanisms for beta-cell dysfunction in minority populations, prevention of acute and chronic diabetic complications, and hospital management of patients with diabetes and hyperglycemia. He is the author of more than 400 scientific manuscripts and book chapters and has presented over 300 research abstracts at national and international scientific meetings. In addition, he heads the Emory Latino Diabetes Education Program, a nationally accredited Spanish Diabetes education program dedicated to providing diabetes education to Latinos.

Otis W. Kirksey currently serves as the Director of Pharmacy Services for Neighborhood Medical Center in Tallahassee, FL. He brings 25 years of experience in academia as a former Professor of Pharmacy Practice at Florida A&M University College of Pharmacy and Pharmaceutical Sciences. Prior to his faculty appointment he was a clinical pharmacist in Research and Information Services at the University of Miami/Jackson Memorial Medical Center. He served more than 11 years on the board of Neighborhood Medical Center and is currently the director of the Prince Hall Shriners' National Diabetes Initiative. In this role, he has led the organization's effort to fulfill its 10-year, $1 million-dollar commitment to the American Diabetes Association, to support research and outreach efforts in underserved communities, particularly African American and Hispanic.

Marshall has a passion for improving the lives of those with Diabetes and has been a volunteer with the American Diabetes Association (ADA) since 2008 serving as a Tour de Cure Corporate and National Team Captain, Silicon Valley Tour Volunteer Chair, Community Leadership Board member, and National ADA Finance Committee member for the past two years. He is an operations-oriented business management leader with strong business acumen. He led public, private, and divisional executive leadership teams through growth and restructuring transformations. Case retired from Lockheed Martin in 2016 as Vice President of Infrastructure Services for the $8B Space Systems Business. Prior to that he was Vice President of Finance and Operations for two Lockheed Martin business units and Executive Vice President and Chief Financial Officer for private and public high technology companies. He started his career on the Financial Management program at General Electric Company in Erie, PA. He now resides in Savannah, GA and is actively involved in community service and pursuing his lifelong love of triathlon competition.